Log in
Enquire now
Maven Biotechnologies

Maven Biotechnologies

A life science instrumentation company developing ellipsometry analysis systems for microplates and slide disposables

OverviewStructured DataIssuesContributors

Contents

mavenbiotech.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Diagnostic tools
Diagnostic tools
Autoimmune disease
Autoimmune disease
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
Pasadena, California
Pasadena, California
B2X
B2B
B2B
CEO
‌
William R. Rassman
AngelList URL
angel.co/maven-biotechnologies
Investors
National Institutes of Health
National Institutes of Health
Total Funding Amount (USD)
2,000,000
Latest Funding Round Date
October 2010
Glassdoor ID
117726
Latest Funding Type
‌
Grant (money)
Patents Assigned (Count)
2
Wellfound ID
maven-biotechnologies
Country
United States
United States

Other attributes

Company Operating Status
Closed

Maven Biotechnology is a California based biotechnology company which develops real-time and label-free imaging technology for protein microarrays, cell-based assays, and multiplex biomarker detection for microplates and disposable slides. The diagnostic technology can include quantitative or qualitative determination of hormones, drugs, metabolic products, tumor markers, autoimmune auto-antibodies, vitamins, and disease agents in biological fluids.

Product

Label Free Internal Reflection Ellipsometry or LFIRE is a real-time polarimetric imaging technology which uses a beam of polarized light directed from the underside of a piece of glass at a specific “critical” angle which is then reflected by the glass-water interface. The reflection produces an electromagnetic wave that responds to the refractive index in the water. A camera with a 12 bit-sensor is used to capture and measure the reflected light beam in real time. The polarization of the reflected beam changes in real time with respect to what the light beam comes in contact with at the interface, which changes its refractive index. This change in polarization allows it to detect small molecules, protein or even cells.

The company’s initial target is immunoassays including various antigen-antibody and kinetic analysis, HCG (Human Chorionic Gonadotropin), species-specific and isotype-specific industrial secondary antibodies. The system can also target autoimmune antigens and infectious disease antigens.

History

William R. Rassman founded the company in 2000 and is headquartered in Pasadena, California.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Maven Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.